-
-
-
-
-
-
-
Liquidia Corporation Announces $100 Million in New Financings
-
-
-
-
-
-
-
Liquidia Enters Into a Revenue Interest Financing Agreement With HealthCare Royalty for Up to $100 Million
-
-
-
-
-
-
-
Liquidia Reports Third Quarter 2021 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Liquidia Resubmits New Drug Application for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension
-
-
-
-
-
-
-
Liquidia Announces Generic Treprostinil Injection Will Be Available for Subcutaneous Route of Administration
-
-
-
-
-
-
-
Liquidia Corporation Appoints Michael Kaseta Chief Financial Officer
-
-
-
-
-
-
-
Liquidia Reports Third Quarter 2020 Financial Results and Provides Corporate Update
-
1,155,355 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

